nodes	percent_of_prediction	percent_of_DWPC	metapath
Procyclidine—Parkinson's disease—Bromocriptine—type 2 diabetes mellitus	0.922	1	CpDpCtD
Procyclidine—CHRM2—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	1.68e-05	0.000214	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.67e-05	0.000214	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—HTR2C—type 2 diabetes mellitus	1.67e-05	0.000214	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—PSMD6—type 2 diabetes mellitus	1.67e-05	0.000214	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—AGT—type 2 diabetes mellitus	1.67e-05	0.000213	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—AGT—type 2 diabetes mellitus	1.66e-05	0.000213	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—EDNRA—type 2 diabetes mellitus	1.65e-05	0.000211	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—AGT—type 2 diabetes mellitus	1.65e-05	0.000211	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—EDNRA—type 2 diabetes mellitus	1.64e-05	0.00021	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—CALM1—type 2 diabetes mellitus	1.64e-05	0.00021	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—CYBA—type 2 diabetes mellitus	1.64e-05	0.00021	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—CALM1—type 2 diabetes mellitus	1.64e-05	0.000209	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—CYBA—type 2 diabetes mellitus	1.64e-05	0.000209	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—EDNRA—type 2 diabetes mellitus	1.63e-05	0.000208	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—CALM1—type 2 diabetes mellitus	1.62e-05	0.000207	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—CYBA—type 2 diabetes mellitus	1.62e-05	0.000207	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	1.61e-05	0.000206	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	1.61e-05	0.000206	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—GHRL—type 2 diabetes mellitus	1.61e-05	0.000205	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—PLAT—type 2 diabetes mellitus	1.61e-05	0.000205	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.6e-05	0.000205	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—GHRL—type 2 diabetes mellitus	1.6e-05	0.000205	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—PLAT—type 2 diabetes mellitus	1.6e-05	0.000205	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	1.59e-05	0.000204	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—CALCA—type 2 diabetes mellitus	1.59e-05	0.000203	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—PLAT—type 2 diabetes mellitus	1.59e-05	0.000203	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—GHRL—type 2 diabetes mellitus	1.59e-05	0.000203	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—CALCA—type 2 diabetes mellitus	1.58e-05	0.000202	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.58e-05	0.000201	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—CALCA—type 2 diabetes mellitus	1.57e-05	0.0002	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	1.54e-05	0.000197	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—C3—type 2 diabetes mellitus	1.54e-05	0.000197	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	1.54e-05	0.000197	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	1.52e-05	0.000195	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.51e-05	0.000193	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—GNB3—type 2 diabetes mellitus	1.51e-05	0.000193	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—HMOX1—type 2 diabetes mellitus	1.5e-05	0.000192	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	1.49e-05	0.000191	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	1.49e-05	0.00019	CbGpPWpGaD
Procyclidine—CHRM1—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	1.49e-05	0.00019	CbGpPWpGaD
Procyclidine—CHRM3—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	1.48e-05	0.00019	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—CAT—type 2 diabetes mellitus	1.48e-05	0.00019	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	1.48e-05	0.000189	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—GCG—type 2 diabetes mellitus	1.47e-05	0.000188	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	1.47e-05	0.000188	CbGpPWpGaD
Procyclidine—CHRM2—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	1.47e-05	0.000188	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.47e-05	0.000188	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.46e-05	0.000187	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—GCG—type 2 diabetes mellitus	1.46e-05	0.000187	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—PTPN1—type 2 diabetes mellitus	1.46e-05	0.000187	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—AGT—type 2 diabetes mellitus	1.46e-05	0.000187	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—GCG—type 2 diabetes mellitus	1.45e-05	0.000185	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—PTPN1—type 2 diabetes mellitus	1.45e-05	0.000185	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	1.45e-05	0.000185	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	1.44e-05	0.000184	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	1.44e-05	0.000184	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—APOB—type 2 diabetes mellitus	1.44e-05	0.000184	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.44e-05	0.000184	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	1.44e-05	0.000184	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—APOE—type 2 diabetes mellitus	1.43e-05	0.000183	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—LEP—type 2 diabetes mellitus	1.43e-05	0.000183	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	1.43e-05	0.000182	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	1.42e-05	0.000182	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.42e-05	0.000181	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—GSTM1—type 2 diabetes mellitus	1.4e-05	0.000179	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	1.38e-05	0.000176	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—LPL—type 2 diabetes mellitus	1.37e-05	0.000176	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—CCL2—type 2 diabetes mellitus	1.37e-05	0.000175	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—CCL2—type 2 diabetes mellitus	1.36e-05	0.000174	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.35e-05	0.000173	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	1.35e-05	0.000173	CbGpPWpGaD
Procyclidine—CHRM1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	1.35e-05	0.000173	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—AKT2—type 2 diabetes mellitus	1.35e-05	0.000172	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—ADCY5—type 2 diabetes mellitus	1.35e-05	0.000172	CbGpPWpGaD
Procyclidine—CHRM3—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	1.35e-05	0.000172	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—GPX1—type 2 diabetes mellitus	1.34e-05	0.000171	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—AKT2—type 2 diabetes mellitus	1.33e-05	0.00017	CbGpPWpGaD
Procyclidine—CHRM2—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	1.33e-05	0.00017	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—CD36—type 2 diabetes mellitus	1.31e-05	0.000167	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—PPP2CA—type 2 diabetes mellitus	1.29e-05	0.000165	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.28e-05	0.000163	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	1.28e-05	0.000163	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	1.27e-05	0.000163	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—GNB3—type 2 diabetes mellitus	1.27e-05	0.000162	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—GNB3—type 2 diabetes mellitus	1.26e-05	0.000161	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	1.26e-05	0.000161	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—GNB3—type 2 diabetes mellitus	1.25e-05	0.00016	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—AVP—type 2 diabetes mellitus	1.25e-05	0.00016	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—MMP3—type 2 diabetes mellitus	1.25e-05	0.00016	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—AVP—type 2 diabetes mellitus	1.25e-05	0.000159	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—MMP3—type 2 diabetes mellitus	1.25e-05	0.000159	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—IGF2—type 2 diabetes mellitus	1.24e-05	0.000159	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—IGF2—type 2 diabetes mellitus	1.24e-05	0.000158	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	1.24e-05	0.000158	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—MTHFR—type 2 diabetes mellitus	1.24e-05	0.000158	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	1.23e-05	0.000158	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—AVP—type 2 diabetes mellitus	1.23e-05	0.000158	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—MMP3—type 2 diabetes mellitus	1.23e-05	0.000158	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—IGF2—type 2 diabetes mellitus	1.23e-05	0.000157	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	1.23e-05	0.000157	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—INS—type 2 diabetes mellitus	1.22e-05	0.000157	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	1.22e-05	0.000156	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	1.22e-05	0.000156	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—PPARA—type 2 diabetes mellitus	1.21e-05	0.000155	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	1.21e-05	0.000155	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—APOB—type 2 diabetes mellitus	1.21e-05	0.000154	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.2e-05	0.000154	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—APOB—type 2 diabetes mellitus	1.2e-05	0.000154	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.2e-05	0.000154	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.2e-05	0.000153	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—APOB—type 2 diabetes mellitus	1.19e-05	0.000152	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.19e-05	0.000152	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.19e-05	0.000152	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.18e-05	0.000151	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.18e-05	0.000151	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.18e-05	0.000151	CbGpPWpGaD
Procyclidine—CHRM4—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.18e-05	0.000151	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—AGT—type 2 diabetes mellitus	1.18e-05	0.00015	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.17e-05	0.00015	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—CALM1—type 2 diabetes mellitus	1.16e-05	0.000148	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—LPL—type 2 diabetes mellitus	1.15e-05	0.000147	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—APOE—type 2 diabetes mellitus	1.15e-05	0.000147	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—LPL—type 2 diabetes mellitus	1.15e-05	0.000147	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—APOA1—type 2 diabetes mellitus	1.14e-05	0.000146	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—LPL—type 2 diabetes mellitus	1.14e-05	0.000145	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.13e-05	0.000144	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.13e-05	0.000144	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.12e-05	0.000144	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.11e-05	0.000142	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.08e-05	0.000138	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.08e-05	0.000138	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.07e-05	0.000137	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.07e-05	0.000137	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.07e-05	0.000137	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.06e-05	0.000136	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.06e-05	0.000135	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.05e-05	0.000134	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—C3—type 2 diabetes mellitus	1.04e-05	0.000133	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—C3—type 2 diabetes mellitus	1.03e-05	0.000132	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—C3—type 2 diabetes mellitus	1.02e-05	0.000131	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—RELA—type 2 diabetes mellitus	1.01e-05	0.000129	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—PPARG—type 2 diabetes mellitus	1e-05	0.000128	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	9.9e-06	0.000127	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—IRS2—type 2 diabetes mellitus	9.88e-06	0.000126	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—HIF1A—type 2 diabetes mellitus	9.87e-06	0.000126	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—AGT—type 2 diabetes mellitus	9.86e-06	0.000126	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—IRS2—type 2 diabetes mellitus	9.85e-06	0.000126	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—INS—type 2 diabetes mellitus	9.84e-06	0.000126	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—AGT—type 2 diabetes mellitus	9.83e-06	0.000126	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	9.77e-06	0.000125	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—IRS2—type 2 diabetes mellitus	9.75e-06	0.000125	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—AGT—type 2 diabetes mellitus	9.74e-06	0.000124	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—CALM1—type 2 diabetes mellitus	9.7e-06	0.000124	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—CALM1—type 2 diabetes mellitus	9.67e-06	0.000124	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—LEP—type 2 diabetes mellitus	9.67e-06	0.000124	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—APOE—type 2 diabetes mellitus	9.67e-06	0.000124	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—LEP—type 2 diabetes mellitus	9.64e-06	0.000123	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—APOE—type 2 diabetes mellitus	9.64e-06	0.000123	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—CALM1—type 2 diabetes mellitus	9.58e-06	0.000122	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—APOA1—type 2 diabetes mellitus	9.55e-06	0.000122	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—LEP—type 2 diabetes mellitus	9.54e-06	0.000122	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—APOE—type 2 diabetes mellitus	9.54e-06	0.000122	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—APOA1—type 2 diabetes mellitus	9.52e-06	0.000122	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—APOA1—type 2 diabetes mellitus	9.43e-06	0.000121	CbGpPWpGaD
Procyclidine—CHRM4—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	9.2e-06	0.000118	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—CASP3—type 2 diabetes mellitus	9.12e-06	0.000117	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	9.12e-06	0.000117	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—PRKCB—type 2 diabetes mellitus	9.09e-06	0.000116	CbGpPWpGaD
Procyclidine—CHRM4—Signaling by GPCR—IL6—type 2 diabetes mellitus	9.06e-06	0.000116	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—ALB—type 2 diabetes mellitus	9.02e-06	0.000115	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	9e-06	0.000115	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—PIK3R1—type 2 diabetes mellitus	8.63e-06	0.00011	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—NOS3—type 2 diabetes mellitus	8.63e-06	0.00011	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—IRS1—type 2 diabetes mellitus	8.62e-06	0.00011	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—MMP9—type 2 diabetes mellitus	8.62e-06	0.00011	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—IRS1—type 2 diabetes mellitus	8.6e-06	0.00011	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—NFKB1—type 2 diabetes mellitus	8.52e-06	0.000109	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—IRS1—type 2 diabetes mellitus	8.51e-06	0.000109	CbGpPWpGaD
Procyclidine—CHRM4—Signaling by GPCR—AKT1—type 2 diabetes mellitus	8.36e-06	0.000107	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—INS—type 2 diabetes mellitus	8.26e-06	0.000106	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—INS—type 2 diabetes mellitus	8.23e-06	0.000105	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—INS—type 2 diabetes mellitus	8.15e-06	0.000104	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—CCL2—type 2 diabetes mellitus	8.12e-06	0.000104	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—CCL2—type 2 diabetes mellitus	8.1e-06	0.000104	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—CCL2—type 2 diabetes mellitus	8.02e-06	0.000103	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—IGF1—type 2 diabetes mellitus	7.99e-06	0.000102	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—AKT2—type 2 diabetes mellitus	7.98e-06	0.000102	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—IGF1—type 2 diabetes mellitus	7.96e-06	0.000102	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—AKT2—type 2 diabetes mellitus	7.96e-06	0.000102	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	7.95e-06	0.000102	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—SRC—type 2 diabetes mellitus	7.94e-06	0.000102	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—EGFR—type 2 diabetes mellitus	7.92e-06	0.000101	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—PTGS2—type 2 diabetes mellitus	7.9e-06	0.000101	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—IGF1—type 2 diabetes mellitus	7.88e-06	0.000101	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—AKT2—type 2 diabetes mellitus	7.88e-06	0.000101	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	7.85e-06	0.0001	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—VEGFA—type 2 diabetes mellitus	7.74e-06	9.89e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	7.58e-06	9.69e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	7.56e-06	9.66e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	7.49e-06	9.57e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	7.24e-06	9.26e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—NOS3—type 2 diabetes mellitus	7.24e-06	9.26e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	7.22e-06	9.23e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—NOS3—type 2 diabetes mellitus	7.22e-06	9.23e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	7.15e-06	9.14e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—NOS3—type 2 diabetes mellitus	7.15e-06	9.14e-05	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.1e-06	9.08e-05	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.96e-06	8.9e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—RELA—type 2 diabetes mellitus	6.82e-06	8.71e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—RELA—type 2 diabetes mellitus	6.79e-06	8.68e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—RELA—type 2 diabetes mellitus	6.73e-06	8.6e-05	CbGpPWpGaD
Procyclidine—CHRM1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	6.21e-06	7.93e-05	CbGpPWpGaD
Procyclidine—CHRM3—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	6.19e-06	7.91e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—CASP3—type 2 diabetes mellitus	6.15e-06	7.86e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—CASP3—type 2 diabetes mellitus	6.13e-06	7.83e-05	CbGpPWpGaD
Procyclidine—CHRM2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	6.13e-06	7.83e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—IL6—type 2 diabetes mellitus	6.11e-06	7.81e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—IL6—type 2 diabetes mellitus	6.09e-06	7.78e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—CASP3—type 2 diabetes mellitus	6.07e-06	7.76e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—IL6—type 2 diabetes mellitus	6.03e-06	7.71e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.81e-06	7.43e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.79e-06	7.4e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.75e-06	7.35e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.74e-06	7.33e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.73e-06	7.32e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.67e-06	7.25e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	5.63e-06	7.2e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	5.62e-06	7.18e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	5.56e-06	7.11e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—SRC—type 2 diabetes mellitus	5.36e-06	6.85e-05	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—IL6—type 2 diabetes mellitus	5.35e-06	6.84e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—SRC—type 2 diabetes mellitus	5.34e-06	6.82e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—SRC—type 2 diabetes mellitus	5.29e-06	6.76e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	5.22e-06	6.67e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	5.2e-06	6.65e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	5.15e-06	6.58e-05	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.94e-06	6.31e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.79e-06	6.12e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.77e-06	6.1e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.73e-06	6.04e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.69e-06	6e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.68e-06	5.98e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.63e-06	5.92e-05	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—AKT1—type 2 diabetes mellitus	3.97e-06	5.07e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—IL6—type 2 diabetes mellitus	3.61e-06	4.61e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—IL6—type 2 diabetes mellitus	3.6e-06	4.6e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—IL6—type 2 diabetes mellitus	3.56e-06	4.55e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.33e-06	4.25e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.32e-06	4.24e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.29e-06	4.2e-05	CbGpPWpGaD
